Oncologists' responsibility, comfort, and knowledge managing hyperglycemia in patients with cancer undergoing chemotherapy: a cross sectional study
- PMID: 37421495
- DOI: 10.1007/s00520-023-07927-9
Oncologists' responsibility, comfort, and knowledge managing hyperglycemia in patients with cancer undergoing chemotherapy: a cross sectional study
Abstract
Purpose: To assess oncologists' responsibility, comfort, and knowledge managing hyperglycemia in patients undergoing chemotherapy.
Methods: In this cross-sectional study, a questionnaire collected oncologists' perceptions about professionals responsible for managing hyperglycemia during chemotherapy; comfort (score range 12-120); and knowledge (score range 0-16). Descriptive statistics were calculated including Student t-tests and one-way ANOVA for mean score differences. Multivariable linear regression identified predictors of comfort and knowledge scores.
Results: Respondents (N = 229) were 67.7% men, 91.3% White and mean age 52.1 years. Oncologists perceived endocrinologists/diabetologists and primary care physicians as those responsible for managing hyperglycemia during chemotherapy, and most frequently referred to these clinicians. Reasons for referral included lack of time to manage hyperglycemia (62.4%), belief that patients would benefit from referral to an alternative provider clinician (54.1%), and not perceiving hyperglycemia management in their scope of practice (52.4%). The top-3 barriers to patient referral were long wait times for primary care (69.9%) and endocrinology (68.1%) visits, and patient's provider outside of the oncologist's institution (52.8%). The top-3 barriers to treating hyperglycemia were lack of knowledge about when to start insulin, how to adjust insulin, and what insulin type works best. Women (ß = 1.67, 95% CI: 0.16, 3.18) and oncologists in suburban areas (ß = 6.98, 95% CI: 2.53, 11.44) had higher comfort scores than their respective counterparts; oncologists working in practices with > 10 oncologists had lower comfort scores (ß = -2.75, 95% CI: -4.96, -0.53) than those in practices with ≤ 10. No significant predictors were identified for knowledge.
Conclusion: Oncologists expected endocrinology or primary care clinicians to manage hyperglycemia during chemotherapy, but long wait times were among the top barriers cited when referring patients. New models that provide prompt and coordinated care are needed.
Keywords: Hyperglycemia; Oncologists; Physicians'; Practice Patterns; Surveys and Questionnaires.
© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Similar articles
-
Optimal hyperglycemia thresholds in patients undergoing chemotherapy: a cross sectional study of oncologists' practices.Support Care Cancer. 2024 Aug 1;32(8):563. doi: 10.1007/s00520-024-08756-0. Support Care Cancer. 2024. PMID: 39088060 Free PMC article.
-
How comfortable are primary care physicians and oncologists prescribing medications for comorbidities in patients with cancer?Res Social Adm Pharm. 2020 Aug;16(8):1087-1094. doi: 10.1016/j.sapharm.2019.11.006. Epub 2019 Nov 9. Res Social Adm Pharm. 2020. PMID: 31734101
-
Portuguese oncologists' practices regarding female fertility preservation: Which barriers most relate to these practices?Eur J Cancer Care (Engl). 2018 Mar;27(2):e12812. doi: 10.1111/ecc.12812. Epub 2018 Jan 4. Eur J Cancer Care (Engl). 2018. PMID: 29314332
-
Oncologists' and pediatric oncologists' perspectives and challenges for fertility preservation.Acta Obstet Gynecol Scand. 2019 May;98(5):598-603. doi: 10.1111/aogs.13551. Epub 2019 Feb 24. Acta Obstet Gynecol Scand. 2019. PMID: 30714120 Review.
-
[Psychometric characteristics of questionnaires designed to assess the knowledge, perceptions and practices of health care professionals with regards to alcoholic patients].Encephale. 2004 Sep-Oct;30(5):437-46. doi: 10.1016/s0013-7006(04)95458-9. Encephale. 2004. PMID: 15627048 Review. French.
Cited by
-
Preliminary guidelines for the detection and management of drug-related problems in cancer patients with type 2 diabetes mellitus: a practical resource for oncology pharmacists.Support Care Cancer. 2024 Nov 14;32(12):791. doi: 10.1007/s00520-024-09014-z. Support Care Cancer. 2024. PMID: 39542931
-
Optimal hyperglycemia thresholds in patients undergoing chemotherapy: a cross sectional study of oncologists' practices.Support Care Cancer. 2024 Aug 1;32(8):563. doi: 10.1007/s00520-024-08756-0. Support Care Cancer. 2024. PMID: 39088060 Free PMC article.
References
-
- Cronin KA, Scott S, Firth AU et al (2022) Annual report to the nation on the status of cancer, part 1: National cancer statistics. Cancer 128:4251–4284. https://doi.org/10.1002/cncr.34479 - DOI - PubMed
-
- Halpern MT, Yabroff KR (2008) Prevalence of outpatient cancer treatment in the United States: estimates from the Medical Panel Expenditures Survey (MEPS). Cancer Invest 26:647–651. https://doi.org/10.1080/07357900801905519 - DOI - PubMed
-
- Henry DH, Viswanathan HN, Elkin EP, Traina S, Wade S, Cella D (2008) Symptoms and treatment burden associated with cancer treatment: results from a cross-sectional national survey in the U.S. Support Care Cancer 16:791–801. https://doi.org/10.1007/s00520-007-0380-2 - DOI - PubMed
-
- Pearce A, Haas M, Viney R et al (2017) Incidence and severity of self-reported chemotherapy side effects in routine care: a prospective cohort study. PLoS One 12:e0184360. https://doi.org/10.1371/journal.pone.0184360 - DOI - PubMed - PMC
-
- Rashid N, Koh HA, Baca HC et al (2015) Clinical impact of chemotherapy-related adverse events in patients with metastatic breast cancer in an integrated health care system. J Manag Care Spec Pharm 21:863–871. https://doi.org/10.18553/jmcp.2015.21.10.863 - DOI - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical